
Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Orkla India reported Q3 FY26 revenue of ₹636 crore with 5.4% volume growth, as spice price deflation softened value growth but supported margin expansion.
Mankind Pharma reported Q2FY26 revenue growth of 20.8% YoY, with chronic therapies outperforming and Bharat Serum and Vaccines consolidation lifting domestic formulations and exports despite GST-led disruption.
UP Hotels’ BSE disclosures cover a voluntary delisting proposal at ₹900, promoter shareholding and no-pledge confirmation, plus FY26 board dates and mixed quarterly financial performance.
Canara Bank has fixed May 15, 2024 as the record date for its 1:5 stock split, dividing each ₹10 face value share into five ₹2 shares.
Public sector banks reported a record FY26 net profit of ₹198,000 crore on better asset quality and credit growth, with operating profit at ₹321,000 crore, the Finance Ministry said.
Sanghvi Movers is seeing higher crane demand and fast-growing EPC revenue, but management is keeping FY26 growth guidance unchanged as expansion costs and competition pressure margins.
Most-active NSE/BSE stocks by volume on 20 May 2026, led by Vodafone Idea, GMR Airports and Fineotex Chemical. Key news triggers, earnings cues and volume-driven moves.
Top traded-by-value stocks on NSE and BSE on 20 May 2026, with catalysts behind major moves across large, mid and small caps and key market context.
Nifty and Sensex ended lower on 20 May 2026. Here is why stocks such as P I Industries, Bharat Electronics, and Pramara Promotions fell on NSE and BSE.
Top gainers on NSE and BSE on 20 May 2026, led by power equipment majors and multiple small-caps hitting upper circuits after results, dividends, and acquisition updates.
BLS International plans ₹2,500 crore investments, targets doubling revenue by 2030, and reports sharp FY26 growth helped by new global visa and Aadhaar contracts.
Brokerages warn India’s FY27 current account deficit could exceed 2% of GDP as crude stays above $100 a barrel and gold prices dilute the impact of import curbs.
Carysil’s Q3 FY26 profit rose 68.6% YoY as margins improved, while investors tracked US tariff cuts, quarterly income trends, capacity plans, and a ₹1,190 target price call.
Eris Lifesciences shares rose after Q4 FY26 results showed a sharp profit jump, steady revenue growth, margin expansion, and an interim dividend with record and payment dates.
The Supreme Court held Coal India and subsidiaries are “enterprises” under the Competition Act, upheld CCI jurisdiction, and separately upheld CIL’s 2006 interim coal pricing policy.
India’s FMCG volume growth could approach 5% in 2026 if crude stays near $80-85 and monsoons hold, but inflation and GST-linked disruptions keep risks elevated.